High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Gynecol Oncol
; 146(2): 247-253, 2017 08.
Article
en En
| MEDLINE
| ID: mdl-28532857
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Piperidinas
/
Benzamidas
/
Neoplasias Endometriales
/
Carcinoma Endometrioide
/
Estatmina
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Gynecol Oncol
Año:
2017
Tipo del documento:
Article